IP Library Assignment 061553/0775
Patent Assignment
Reel/Frame 061553/0775

Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 022142 Frame: 0111. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2022-09-27 Pages: 12
Assignors
ZON, GERALD
Executed: 2007-07-30
LEBEDEV, ALEXANDRE
Executed: 2007-07-11
Assignee
TRILINK BIOTECHNOLOGIES, INCORPORATED
9955 MESA RIM ROAD, SAN DIEGO, CALIFORNIA, 92109
Covered Property (1)
Phosphotriester-Modified Oligonucleotide Primers for Nucleic Acid Amplification
Patent: 8,361,753 →
Application: 11/750,237 →
Publication: US 2007/0281308
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest Feb 16, 2017
From: TRILINK BIOTECHNOLOGIES, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 041277/0753 →
Security Agreement Aug 2, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 046708/0095 →
Security Agreement Aug 3, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 046702/0651 →
Release and Reassignment of Security Interest Recorded at Reel/Frame 41277/0753 Sep 13, 2018
From: NXT CAPITAL, LLC
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 047089/0675 →
Security Agreement Oct 19, 2020
From: MARAVAI LIFE SCIENCES, INC.; TRILINK BIOTECHNOLOGIES, LLC; VECTOR LABORATORIES, INC.; GLEN RESEARCH, LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 054118/0848 →
Release of Second Lien Security Interest Oct 19, 2020
From: ANTARES CAPITAL LP
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0763 →
Release of First Lien Security Interest Oct 19, 2020
From: JPMORGAN CHASE BANK, N.A.
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0751 →
Change of Name Dec 14, 2022
From: TRILINK BIOTECHNOLOGIES, INCORPORATED
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 062124/0819 →